Caspase-6 does not contribute to the proteolysis of mutant huntingtin in the HdhQ150 Knock-in mouse model of Huntington's disease

PLoS Currents

Volumn , Issue , 2012, Pages

  Landles, Christian ^a   Weiss, Andreas ^b   Franklin, Sophie ^c   Howland, David ^d   Bates, Gill P ^c  

^a GUY S HOSPITAL   (United Kingdom)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d CHDI MANAGEMENT CHDI FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 6; HUNTINGTIN;

ABLATION THERAPY; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HUNTINGTON CHOREA; IMMUNOPRECIPITATION; MALE; MOUSE; MUTANT; NONHUMAN; PROTEIN DEGRADATION; STEADY STATE; WESTERN BLOTTING; ANIMAL TISSUE; GENE TARGETING; PROTEIN DEPLETION; PROTEIN EXPRESSION; BRAIN TISSUE; GENOTYPING TECHNIQUE; IMMUNODETECTION; PROTEIN CLEAVAGE;

EID: 84867459264     PISSN: None     EISSN: 21573999     Source Type: Journal    
DOI: 10.1371/4fd085bfc9973     Document Type: Article

References (27)

1. Bates GP, Benn C (2002) The Polyglutamine Diseases. In: Bates GP, Harper PS, Jones AL, editors. Huntington's Disease. 3rd ed. Oxford: Oxford University Press. pp. 429-472.
2. Landles C, Bates GP (2004) Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series. EMBO Rep 5: 958-963.
3. Harjes P, Wanker EE (2003) The hunt for huntingtin function: interaction partners tell many different stories. Trends Biochem Sci 28: 425-433.
4. Lin CH, Tallaksen-Greene S, Chien WM, Cearley JA, Jackson WS, et al. (2001) Neurological abnormalities in a knock-in mouse model of Huntington's disease. Hum Mol Genet 10: 137-144.
5. Woodman B, Butler R, Landles C, Lupton MK, Tse J, et al. (2007) The Hdh(Q150/Q150) knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypes. Brain Res Bull 72: 83-97.
6. Landles C, Sathasivam K, Weiss A, Woodman B, Moffitt H, et al. (2010) Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease. J Biol Chem 285: 8808-8823.
7. DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, et al. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277: 1990-1993.
8. Lunkes A, Lindenberg KS, Ben-Haiem L, Weber C, Devys D, et al. (2002) Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions. Mol Cell 10: 259-269.
9. Ratovitski T, Nakamura M, D'Ambola J, Chighladze E, Liang Y, et al. (2007) N-terminal proteolysis of fulllength mutant huntingtin in an inducible PC12 cell model of Huntington's disease. Cell Cycle 6: 2970-2981.
10. Ratovitski T, Gucek M, Jiang H, Chighladze E, Waldron E, et al. (2009) Mutant huntingtin N-terminal fragments of specific size mediate aggregation and toxicity in neuronal cells. J Biol Chem 284: 10855-10867.
11. Wellington CL, Ellerby LM, Gutekunst CA, Rogers D, Warby S, et al. (2002) Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease. J Neurosci 22: 7862-7872.
12. Kim YJ, Yi Y, Sapp E, Wang Y, Cuiffo B, et al. (2001) Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Proc Natl Acad Sci U S A 98: 12784-12789.
13. Gafni J, Hermel E, Young JE, Wellington CL, Hayden MR, et al. (2004) Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain/caspase fragments in the nucleus. J Biol Chem 279: 20211-20220.
14. Miller JP, Holcomb J, Al-Ramahi I, de Haro M, Gafni J, et al. (2010) Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease. Neuron 67: 199-212.
15. Kim YJ, Sapp E, Cuiffo BG, Sobin L, Yoder J, et al. (2006) Lysosomal proteases are involved in generation of N-terminal huntingtin fragments. Neurobiol Dis 22: 346-356.
16. Schilling G, Klevytska A, Tebbenkamp AT, Juenemann K, Cooper J, et al. (2007) Characterization of huntingtin pathologic fragments in human Huntington disease, transgenic mice, and cell models. J Neuropathol Exp Neurol 66: 313-320.
17. Sun B, Fan W, Balciunas A, Cooper JK, Bitan G, et al. (2002) Polyglutamine repeat length-dependent proteolysis of huntingtin. Neurobiol Dis 11: 111-122.
18. Tanaka Y, Igarashi S, Nakamura M, Gafni J, Torcassi C, et al. (2006) Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin. Neurobiol Dis 21: 381-391.
19. Waldron-Roby E, Ratovitski T, Wang X, Jiang M, Watkin E, et al. (2012) Transgenic mouse model expressing the caspase 6 fragment of mutant huntingtin. J Neurosci 32: 183-193.
20. Graham RK, Deng Y, Slow EJ, Haigh B, Bissada N, et al. (2006) Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell 125: 1179-1191.
21. Sathasivam K, Lane A, Legleiter J, Warley A, Woodman B, et al. (2010) Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease. Hum Mol Genet 19: 65-78.
22. Uribe V, Wong BK, Graham RK, Cusack CL, Skotte NH, et al. (2012) Rescue from excitotoxicity and axonal degeneration accompanied by age-dependent behavioral and neuroanatomical alterations in caspase-6-deficient mice. Hum Mol Genet 21: 1954-1967.
23. Ko J, Ou S, Patterson PH (2001) New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins. Brain Res Bull 56: 319-329.
24. Weiss A, Abramowski D, Bibel M, Bodner R, Chopra V, et al. (2009) Single-step detection of mutant huntingtin in animal and human tissues: a bioassay for Huntington's disease. Anal Biochem 395: 8-15.
25. Weiss A, Grueninger S, Abramowski D, Giorgio FP, Lopatin MM, et al. (2011) Microtiter plate quantification of mutant and wild-type huntingtin normalized to cell count. Anal Biochem 410: 304-306.
26. Sathasivam K, Woodman B, Mahal A, Bertaux F, Wanker EE, et al. (2001) Centrosome disorganization in fibroblast cultures derived from R6/2 Huntington's disease (HD) transgenic mice and HD patients. Hum Mol Genet 10: 2425-2435.
27. Gafni J, Papanikolaou T, Degiacomo F, Holcomb J, Chen S, et al. (2012) Caspase-6 Activity in a BACHD Mouse Modulates Steady-State Levels of Mutant Huntingtin Protein But Is Not Necessary for Production of a 586 Amino Acid Proteolytic Fragment. J Neurosci 32: 7454-7465.